In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases.
In this episode, we cover:
- How Orion approaches non-molecular innovation
- Solving misconceptions in digital medicine
- VR as a modality for DTx
- Patient experience using VR
- Approaches to evidence generation
- Commercializing stand alone DTx vs Drug+
Guest Links and Resources:
- Connect with Sammeli Liikkanen on LinkedIn
- Visit https://www.orion.fi/en/
Working on a biomarker? Click here to tell Sammeli and his team about it!
Host Links:
- Connect with Eugene Borukhovich: Twitter | LinkedIn
- Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
- Connect with YourCoach.health: Website | Twitter
- Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
- HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
